Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency

被引:93
作者
Duverger, Alexandra [1 ]
Jones, Jennifer [1 ]
May, Jori [1 ]
Bibollet-Ruche, Frederic [1 ]
Wagner, Frederic A. [1 ]
Cron, Randall Q. [1 ]
Kutsch, Olaf [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, BBRB, Div Infect Dis, Birmingham, AL 35294 USA
关键词
LONG TERMINAL REPEAT; CD4(+) T-CELLS; NF-KAPPA-B; ACTIVE ANTIRETROVIRAL THERAPY; TUMOR NECROSIS FACTOR; HIV-1; INFECTION; TRANSCRIPTIONAL ACTIVATION; HISTOGENETIC SUBSETS; VALPROIC ACID; IN-VITRO;
D O I
10.1128/JVI.02058-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent research has emphasized the notion that human immunodeficiency virus type 1 (HIV-1) latency is controlled by a restrictive histone code at, or DNA methylation of, the integrated viral promoter (long terminal repeat [LTR]). The present concept of HIV-1 latency has essentially been patterned from the principles of cellular gene regulation. Here we introduce an experimental system that allows for the qualitative and quantitative kinetic study of latency establishment and maintenance at the population level. In this system, we find no evidence that HIV-1 latency establishment is the consequence of downregulation of initial active infection followed by the establishment of a restrictive histone code at the viral LTR. Latent infection was established following integration of the virus in the absence of viral gene expression (silent integration) and was a function of the NF-kappa B activation level in the host cell at the time of infection. In the absence of a role for epigenetic regulation, we demonstrate that transcriptional interference, a mechanism that has recently been suggested to add to the stabilization of HIV-1 latency, is the primary mechanism to govern latency maintenance. These findings provide direct experimental evidence that the high number of viral integration events (>90%) found in actively expressed genes of CD4(+) memory T cells from highly active antiretroviral therapy-suppressed patients represent indeed latent infection events and that transcriptional interference may be the primary mechanism to control HIV-1 latency in vivo. HIV-1 latency may thus not be governed by the principles of cellular gene regulation, and therapeutic strategies to deplete the pool of latently HIV-1-infected cells should be reconsidered.
引用
收藏
页码:3078 / 3093
页数:16
相关论文
共 61 条
  • [1] CELLULAR LATENCY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS WITH HIGH CD4 LEVELS CAN BE DETECTED BY THE PRESENCE OF PROMOTER-PROXIMAL TRANSCRIPTS
    ADAMS, M
    SHARMEEN, L
    KIMPTON, J
    ROMEO, JM
    GARCIA, JV
    PETERLIN, BM
    GROUDINE, M
    EMERMAN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3862 - 3866
  • [2] HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration
    Agosto, Luis M.
    Yu, Jianqing J.
    Dai, Jihong
    Kaletsky, Rachel
    Monie, Daphne
    O'Doherty, Una
    [J]. VIROLOGY, 2007, 368 (01) : 60 - 72
  • [3] INACTIVATION OF THE HIV LTR BY DNA CPG METHYLATION - EVIDENCE FOR A ROLE IN LATENCY
    BEDNARIK, DP
    COOK, JA
    PITHA, PM
    [J]. EMBO JOURNAL, 1990, 9 (04) : 1157 - 1164
  • [4] METHYLATION AS A MODULATOR OF EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS
    BEDNARIK, DP
    MOSCA, JD
    RAJ, NBK
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (04) : 1253 - 1257
  • [5] COOPERATIVE INHIBITION OF NF-KAPPA-B AND TAT-INDUCED SUPERACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT
    BISWAS, DK
    AHLERS, CM
    DEZUBE, BJ
    PARDEE, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) : 11044 - 11048
  • [6] Generation of HIV latency during thymopoiesis
    Brooks, DG
    Kitchen, SG
    Kitchen, CMR
    Scripture-Adams, DD
    Zack, JA
    [J]. NATURE MEDICINE, 2001, 7 (04) : 459 - 464
  • [7] INTEGRATION OF HUMAN-IMMUNODEFICIENCY-VIRUS DNA - ADDUCT INTERFERENCE ANALYSIS OF REQUIRED DNA SITES
    BUSHMAN, FD
    CRAIGIE, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) : 3458 - 3462
  • [8] Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities
    Butera, ST
    [J]. ANTIVIRAL RESEARCH, 2000, 48 (03) : 143 - 176
  • [9] Carbone A, 1998, BLOOD, V91, P747
  • [10] Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
    Carbone, A
    Gloghini, A
    Larocca, LM
    Capello, D
    Pierconti, F
    Canzonieri, V
    Tirelli, U
    Dalla-Favera, R
    Gaidano, G
    [J]. BLOOD, 2001, 97 (03) : 744 - 751